Chemoinformaics analysis of DIHYDROXYGLUTAMIC-ACID
Molecular Weight | 182.084 | nRot | 3 |
Heavy Atom Molecular Weight | 176.036 | nRig | 2 |
Exact Molecular Weight | 182.006 | nRing | 0 |
Solubility: LogS | -0.934 | nHRing | 0 |
Solubility: LogP | -0.343 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
nHA | 6 | APOL | 17.0968 |
nHD | 6 | BPOL | 7.75524 |
QED | 0.246 |
Synth | 3.125 |
Natural Product Likeliness | 0.493 |
NR-PPAR-gamma | 0 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.093 |
HIA | 0.768 |
CACO-2 | -6.377 |
MDCK | 0.0271714 |
BBB | 0.814 |
PPB | 0.162215 |
VDSS | 0.342 |
FU | 0.840282 |
CYP1A2-inh | 0.009 |
CYP1A2-sub | 0.029 |
CYP2c19-inh | 0.021 |
CYP2c19-sub | 0.049 |
CYP2c9-inh | 0.015 |
CYP2c9-sub | 0.007 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.058 |
CYP3a4-inh | 0.068 |
CYP3a4-sub | 0.021 |
CL | 1 |
T12 | 0.546 |
hERG | 0.005 |
Ames | 0.007 |
ROA | 0.011 |
SkinSen | 0.048 |
Carcinogencity | 0.004 |
EI | 0.965 |
Respiratory | 0.023 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.860927 |